21 – 30 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Governing, protecting, and regulating the future of genome editing : The significance of ELSI perspectives
- Contribution to journal › Article
- 2021
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
(2021)
- Book/Report › Report
- 2020
-
Mark
Special issue on legal landscape concerning the coronavirus outbreak – part II
(2020) 2020:2.
- Other contribution › Miscellaneous
-
Mark
Applying the Proportionality Principle to COVID-19 Antibody Testing
(2020) In Journal of Law and the Biosciences
- Contribution to journal › Article
-
Mark
Ethical and Legal Challenges of Artificial Intelligence-Driven Health Care
(2020) p.295-336
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges: Available at: https://blog.petrieflom.law.harvard.edu/2020/05/12/sweden-global-responses-covid19/
(2020)
- Other contribution › Miscellaneous
-
Mark
Regulatory responses to medical machine learning
- Contribution to journal › Article
-
Mark
Establishing the First International Genetic Discrimination Observatory
- Contribution to journal › Article
-
Mark
Clinical trial data transparency and GDPR compliance: Implications for data sharing and open innovation
(2020) In Science and Public Policy
- Contribution to journal › Article
-
Mark
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?
- Contribution to journal › Article
